ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | -77.8% | 6,600 | -68.7% | 0.00% | -100.0% |
| Q1 2017 | $9,000 | +125.0% | 21,100 | +145.3% | 0.00% | – |
| Q4 2016 | $4,000 | +33.3% | 8,600 | +30.3% | 0.00% | – |
| Q3 2016 | $3,000 | -40.0% | 6,600 | +43.5% | 0.00% | -100.0% |
| Q2 2016 | $5,000 | -54.5% | 4,600 | -0.7% | 0.00% | -50.0% |
| Q4 2014 | $11,000 | -8.3% | 4,633 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $12,000 | -29.4% | 4,633 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $17,000 | -79.0% | 4,633 | -32.9% | 0.00% | -81.8% |
| Q1 2014 | $81,000 | +376.5% | 6,900 | +246.4% | 0.01% | +266.7% |
| Q4 2013 | $17,000 | -5.6% | 1,992 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $18,000 | -63.3% | 1,992 | -60.2% | 0.00% | -72.7% |
| Q2 2013 | $49,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 396,104 | $400,000 | 0.42% |
| Ancora Advisors LLC | 50,865 | $51,000 | 0.01% |
| Acrospire Investment Management LLC | 5,200 | $5,000 | 0.00% |
| EAGLE GLOBAL ADVISORS LLC | 145,710 | $146,000 | 0.00% |
| A.R.T. Advisors, LLC | 57,954 | $57,000 | 0.00% |
| Renaissance Technologies | 876,100 | $876,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 133,846 | $134,000 | 0.00% |
| Cutler Group LLC / CA | 11,048 | $11,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 4,600 | $5,000 | 0.00% |
| Timber Hill LLC | 10,663 | $11,000 | 0.00% |